Who to call at Cartesian Therapeutics, Inc., and when
Fundz watches for the moments Cartesian Therapeutics, Inc. starts buying, and tells you who to reach.
- An alert the day Cartesian Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cartesian Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cartesian Therapeutics, Inc.. With Fundz connected, it knows.
Cartesian Therapeutics, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
selectabio.comAI Executive Summary
AI-powered analysis of 8-K filing content
Carrie S. Cox resigned from Cartesian Therapeutics' Board of Directors effective October 29, 2025, citing her new role as Executive Chair of another public company, and ceased her roles as Board Chairman, Compensation Committee Chair and Audit Committee member. The Board named Carsten Brunn, Ph.D. as Chairman, Patrick Zenner as Lead Independent Director and Kemal Malik as Compensation Committee Chair.
Key Takeaways
Carrie S. Cox resigned effective immediately on October 29, 2025, due to added responsibilities from her appointment as Executive Chair of another publicly traded company, and the filing states the re
Cox had served as Board Chairman since 2019 and chaired the Compensation Committee, so the Board had to fill both roles along with her Audit Committee seat.
3 more takeaways
Filing Overview
What This Means
Cartesian Therapeutics, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.